SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Balcer, L. J
Right arrow Articles by Maguire, M. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balcer, L. J
Right arrow Articles by Maguire, M. G
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Self-reported visual dysfunction in multiple sclerosis: results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25)

Laura J Balcer

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA, Department of Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Monika L Baier

Department of Biostatistics, AMC Cancer Research Center, Denver, Colorado, USA

Amy M Kunkle

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Richard A Rudick

Department of Neurology, Cleveland Clinic Foundation, Cleveland, Ohio, USA

Bianca Weinstock-Guttman

Department of Neurology, University of Buffalo, Buffalo, New York, USA

Nancy Simonian

Biogen, Fourteen Cambridge Center, Cambridge, Massachusetts, MA 02142, USA

Steven L Galetta

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA, Department of Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Gary R Cutter

Department of Biostatistics, AMC Cancer Research Center, Denver, Colorado, USA

Maureen G Maguire

Department of Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA, Department of Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Visual impairment is one of the most common clinical manifestations of Multiple Sclerosis (MS), and is strongly related to overall health-related quality of life (HRQOL) in MS and other disorders. However, the assessment of vision-specific HRQOL in patients with MS has been limited. The purpose of this study was to examine self-reported visual dysfunction in a clinically heterogeneous MS cohort using the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25). The VFQ-25 was administered by telephone interview to a subset of participants in a follow-up study to a phase III trial of interferon ß-1a for relapsing-remitting MS. Mean VFQ-25 composite scores and selected sub-scale scores were significantly lower (worse) among patients in our MS cohort (n=35) compared with a published reference group of patients with no history of chronic eye disease (n=118). These differences were observed despite a relatively younger age and tighter distribution of binocular visual acuities in the MS cohort. Patients with MS in this study thus demonstrated a greater degree of self-reported visual dysfunction, as measured by the VFQ-25, compared with an eye disease-free reference group. The VFQ-25 is a potentially useful measure of vision-specific HRQOL in patients with MS.

Key Words: vision • health-related quality of life • multiple sclerosis • MS • VFQ-25 • NEI-VFQ

Multiple Sclerosis, Vol. 6, No. 6, 382-385 (2000)
DOI: 10.1177/135245850000600604


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
R. T. Naismith, N. T. Tutlam, J. Xu, J. B. Shepherd, E. C. Klawiter, S. -K. Song, and A. H. Cross
Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis
Neurology, July 7, 2009; 73(1): 46 - 52.
[Abstract] [Full Text] [PDF]



Advertisement